Central venous catheterisation: Which Medications Cause It? (2,471 Reports Across 119 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Central venous catheterisation has been reported as an adverse event with 119 different drugs in the FDA's FAERS database, with 2,471 total reports. 156 of these reports resulted in death.The drugs most commonly associated with Central venous catheterisation are EPOPROSTENOL, AMBRISENTAN, and TREPROSTINIL.
2,471
Total Reports
119
Drugs Involved
156
Deaths
1,499
Hospitalizations
47.5 yrs
Average Patient Age
65.9% / 34.1%
Female / Male
Which Drugs Cause Central venous catheterisation Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| EPOPROSTENOL | 361 | 2.7% | 39 | 305 | 10 |
| AMBRISENTAN | 263 | 0.3% | 10 | 189 | 0 |
| TREPROSTINIL | 208 | 0.2% | 4 | 159 | 4 |
| ECULIZUMAB | 105 | 0.2% | 3 | 27 | 1 |
| VENETOCLAX | 89 | 0.2% | 4 | 40 | 2 |
| MACITENTAN | 78 | 0.2% | 7 | 72 | 0 |
| PEMBROLIZUMAB | 70 | 0.1% | 13 | 30 | 3 |
| AZTREONAM LYSINE | 63 | 0.5% | 0 | 39 | 0 |
| ADALIMUMAB | 59 | 0.0% | 2 | 40 | 2 |
| NATALIZUMAB | 57 | 0.1% | 1 | 30 | 0 |
| GLYCINE\MANNITOL\SODIUM | 56 | 4.5% | 6 | 44 | 1 |
| HUMAN C1-ESTERASE INHIBITOR | 53 | 0.4% | 0 | 30 | 2 |
| IBRUTINIB | 49 | 0.1% | 1 | 22 | 0 |
| RIOCIGUAT | 42 | 0.2% | 6 | 37 | 0 |
| LARONIDASE | 38 | 1.2% | 4 | 15 | 0 |
| AMIKACIN | 31 | 0.3% | 5 | 19 | 0 |
| CARBOPLATIN | 31 | 0.0% | 6 | 15 | 4 |
| ELOSULFASE ALFA | 31 | 0.6% | 0 | 8 | 0 |
| RISANKIZUMAB-RZAA | 31 | 0.1% | 1 | 17 | 0 |
| HUMAN IMMUNOGLOBULIN G | 30 | 0.0% | 0 | 12 | 1 |